363-03-013
MRI in Clinical Practice Abstract
Evaluation of Treatment Response in Lung Cancer based on GRASP Dynamic Contrast-Enhanced MRI
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. DUPUY D E, FERNANDO H C, HILLMAN S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial [J]. Cancer, 2015, 121(19): 3491-8.DOI: https://dx.doi.org/10.1002/cncr.29507 [doi]
2. KOH T S, BISDAS S, KOH D M, et al. Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI [J]. J Magn Reson Imaging, 2011, 34(6): 1262-76.DOI: https://dx.doi.org/10.1002/jmri.22795 [doi]
3. CHEN L, LIU D, ZHANG J, et al. Free-breathing dynamic contrast-enhanced MRI for assessment of pulmonary lesions using golden-angle radial sparse parallel imaging [J]. J Magn Reson Imaging, 2018, 48(2): 459-68.DOI: https://dx.doi.org/10.1002/jmri.25977 [doi]
4. CHEN L, ZENG X, WU Y, et al. A Study of the Correlation of Perfusion Parameters in High-Resolution GRASP MRI With Microvascular Density in Lung Cancer [J]. J Magn Reson Imaging, 2019, 49(4): 1186-94.DOI: https://dx.doi.org/10.1002/jmri.26340 [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/363-03-013